This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| European Foundation for the Study of Diabetes | |
|---|---|
| Name | European Foundation for the Study of Diabetes |
| Formation | 1999 |
| Headquarters | Brussels |
| Region served | Europe |
| Leader title | President |
European Foundation for the Study of Diabetes is a Brussels-based philanthropic foundation supporting research, education, and policy related to diabetes across Europe. The foundation provides grants, fellowships, and educational programs that intersect with major institutions, societies, and agencies in Brussels, Geneva, London, Paris, and other European capitals. Its activities engage clinical centers, academic institutions, regulatory bodies, professional associations, and patient organizations such as World Health Organization, European Commission, European Medicines Agency, International Diabetes Federation, and national diabetes societies.
The foundation was established at the turn of the 21st century with roots in collaborations among clinicians and researchers from Karolinska Institute, University of Oxford, University of Cambridge, Imperial College London, and Université Paris-Sorbonne. Early supporters included stakeholders from European Society of Cardiology, European Respiratory Society, European Association for the Study of Obesity, and charitable entities linked to Wellcome Trust, Bill & Melinda Gates Foundation, and Novo Nordisk Foundation. It developed programs in parallel with initiatives at Harvard Medical School, Stanford University, Johns Hopkins University, and major European universities such as KU Leuven, University of Copenhagen, Heidelberg University, University of Amsterdam, and Sorbonne University. Milestones included partnerships with European Federation of Pharmaceutical Industries and Associations, participation in consortia with Horizon 2020, and alignment with guidance from European Centre for Disease Prevention and Control.
The foundation’s mission aligns research funding with capacity building and policy influence, advancing translational science and clinical practice in partnership with entities such as European Society for Clinical Nutrition and Metabolism, European Renal Association–European Dialysis and Transplant Association, European Association for the Study of Liver, and European Association for the Study of Obesity. Objectives include fostering investigator-initiated projects at institutions like University College London, Trinity College Dublin, Università degli Studi di Milano, and University of Barcelona; supporting early-career investigators affiliated with Mayo Clinic, Cleveland Clinic, Charité – Universitätsmedizin Berlin, and Erasmus University Rotterdam; and informing policy dialogues involving Council of Europe, Organisation for Economic Co-operation and Development, and national ministries of health such as Ministry of Health (France), NHS England, and Ministerio de Sanidad (Spain).
Governance structures reflect input from clinicians, researchers, and patient advocates connected to organizations like European Diabetes Forum, Federation of European Biochemical Societies, European Clinical Research Infrastructure Network, and academic councils at University of Oxford Medical Sciences Division, ETH Zurich, and Uppsala University. Boards routinely include representatives from specialty societies including European Association for the Study of Diabetes, European Society of Paediatric Endocrinology, and professional groups such as Royal College of Physicians, Royal College of General Practitioners, and Academy of Medical Sciences. Advisory committees liaise with regulators and funders such as European Medicines Agency, National Institutes of Health, German Research Foundation, French National Centre for Scientific Research, and philanthropic partners like Gates Foundation and Wellcome Trust.
Research grants and fellowships support projects at centers linked to Pasteur Institute, MRC Clinical Trials Unit, Max Planck Society, CNRS, Institut de Recerca Hospital del Mar, and Karolinska Institutet. Programs target basic science in collaboration with laboratories at Broad Institute, EMBL, and Francis Crick Institute; clinical trials coordinated with networks like European Clinical Research Infrastructure Network and European Organisation for Research and Treatment of Cancer; and epidemiology using cohorts such as UK Biobank, EPIC, and Framingham Heart Study. Funding mechanisms mirror models used by Horizon Europe, European Research Council, Wellcome Trust, and national research councils including UK Research and Innovation and Austrian Science Fund.
Education efforts include summer schools, workshops, and fellowships held in collaboration with universities and societies such as University of Oxford, University of Cambridge, Karolinska Institute, University of Milan, Swiss Institute of Allergy and Asthma Research, European Society of Endocrinology, and International Society for Pediatric and Adolescent Diabetes. Training programs target clinicians and researchers affiliated with hospitals like Rabin Medical Center, Hôpital Pitié-Salpêtrière, University Hospital Leuven, Rigshospitalet, and Sahlgrenska University Hospital, and include exchanges with laboratories at Salk Institute, Institut Pasteur, and Max Planck Institute of Metabolism Research.
The foundation partners with a wide array of institutions: regulatory agencies such as European Medicines Agency, funders like European Research Council, academic centers including University of Oxford, Karolinska Institutet, University of Copenhagen, professional associations such as European Association for the Study of Diabetes, and patient groups exemplified by European Diabetes Forum. It engages in consortia with initiatives like Horizon Europe, networks such as European Clinical Research Infrastructure Network, and industry partners including Novo Nordisk, Sanofi, Eli Lilly and Company, Roche, and AstraZeneca.
Contributions include supported trials influencing guidelines from bodies like European Society of Cardiology, European Association for the Study of Diabetes, and national guideline committees in United Kingdom, Germany, France, Italy, and Spain. The foundation’s outputs inform public health strategies adopted by World Health Organization, European Commission, and national health ministries, and underpin translational advances at centers including Karolinska Institutet, Imperial College London, and Leiden University Medical Center. Its fellows and grantees have published in journals affiliated with BMJ, The Lancet, New England Journal of Medicine, Diabetologia, and Diabetes Care, contributing to practice changes in insulin therapy, prevention programs linked to Diabetes Prevention Program, and technologies such as continuous glucose monitoring developed by companies like Dexcom and Medtronic.
Category:Medical foundations